Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CM | C |
|---|---|---|
| Price | $111.55 | $132.49 |
| Change today | ▲ 0.09% | ▲ 0.42% |
| Market cap | $101.82B | $222.24B |
| Return, 3 months | -1.3% | -7.3% |
| Return, year to date | +25.0% | +15.3% |
| Return, 1 year | +42.7% | +33.1% |
| P/E (TTM) | 15.1 | 14.3 |
| P/B | 2.4 | 1.2 |
| P/E percentile vs own 5y | 92nd | 69th |
| Dividend yield | 2.67% | 1.81% |
| Revenue growth (YoY, latest qtr) | +15.3% | +14.3% |
| Net profit growth (YoY) | +14.9% | +49.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 30.0% | 18.0% |
| Return on equity | 16.8% | 8.5% |
| Analyst target vs. price | +12.7% | +19.0% |
| Analyst buy share | 57% | 79% |
| RSI (14) | 45 | 46 |
| 30-day volatility | 23.4% | 22.5% |
| Max drawdown, 1 year | -10.8% | -14.8% |
| Trend read | Mixed | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.